Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTS Analog Classroom Study in Pediatric ADHD
NCT00466791Phase 2Completed
- Sponsor
- Noven Therapeutics, LLC
- Start
- Aug 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate Transdermal System with Placebo (2 arms). Primary endpoint: Swanson, Kotkin, Agler, M-Flynn, and Pelham Rating Scale at 12 hours. Started Aug 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00466791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466791.